Euronext (ENX) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
The AGM was held on 15 May 2025, focusing on 2024 performance and future strategy, with all key board members, nominees, and the external auditor present; 84.85% of issued capital was represented and voting rights confirmed.
Financial performance review
FY 2024 revenue grew 10.3% to €1,626.9m, with adjusted EBITDA up 16.4% to €1,006.4m and a margin of 61.9%.
Adjusted net income rose 16.7% to €682.5m, with adjusted EPS at €6.59.
Non-volume revenue comprised 58% to nearly 80% of total, reflecting diversification and strong growth in custody, settlement, data services, and listings.
Net operating cash flow totaled €708.6m for the year.
Share price since IPO increased by 740%, with €1.7 billion returned via dividends and €500 million via share buybacks.
Dividend announcements
A dividend of €2.90 per share was proposed and adopted, up 16.9% from the previous year, maintaining a 50% payout ratio; total proposed dividend for 2024 was €292.8m, a 14.0% increase, subject to shareholder approval.
Dividend payout policy set at 50% of reported net income, with potential for special returns.
Latest events from Euronext
- Double-digit revenue and EBITDA growth in 2025, with strong cost discipline and strategic expansion.ENX
Q4 202519 Feb 2026 - Record Q2 2024 revenue and profit growth, with integration and innovation fueling expansion.ENX
Q2 20242 Feb 2026 - Q3 2024 delivered double-digit growth, early target achievement, and a €300m buyback launch.ENX
Q3 & CMD 202415 Jan 2026 - Record revenue, margin expansion, and acquisitions drive growth and innovation for 2025.ENX
Q4 20248 Jan 2026 - Double-digit growth in revenue, profit, and trading volumes in Q1 2025.ENX
Q1 202518 Nov 2025 - Double-digit growth, margin gains, and a €250M buyback underscore a strong Q3 2025.ENX
Q3 20257 Nov 2025 - Record Q2 2025 results with 12.8% revenue growth, major acquisitions, and strong market conditions.ENX
Q2 202531 Oct 2025